Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting

• Published in: The American journal of cardiology Vol. 121; no. 6; pp. 709 - 714
• Main Authors: Ebrahimi, Ramin, Gupta, Sandeep, Carr, Brendan M., Bishawi, Muath, Bakaeen, Faisal G., Almassi, G. Hossein, Collins, Joseph, Grover, Frederick L., Quin, Jacquelyn A., Wagner, Todd H., Shroyer, A. Laurie W., Hattler, Brack
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.03.2018; Elsevier Limited
• Subjects: Acute coronary syndromes; Aged; Angina pectoris; Aspirin; Aspirin - administration & dosage; Aspirin - economics; Bypasses; Cardiovascular disease; Clinical outcomes; Clopidogrel; Clopidogrel - administration & dosage; Clopidogrel - economics; Comorbidity; Coronary artery; Coronary Artery Bypass; Coronary Disease - mortality; Coronary Disease - surgery; Coronary vessels; Cost analysis; Costs; Costs and Cost Analysis; Data collection; Drug Therapy, Combination; Endoscopy; Female; Government agencies; Heart; Heart attacks; Heart surgery; Hospitals, Veterans; Humans; Male; Middle Aged; Morbidity; Myocardial infarction; Patients; Platelet Aggregation Inhibitors - administration & dosage; Platelet Aggregation Inhibitors - economics; Postoperative Complications - economics; Postoperative Complications - epidemiology; Postoperative Complications - prevention & control; Prospective Studies; R&D; Research & development; Therapy; Treatment Outcome; Ventricle
• ISSN: 0002-9149; 1879-1913; 1879-1913
• DOI: 10.1016/j.amjcard.2017.12.010

Optimal antiplatelet therapy after coronary artery bypass graft (CABG) surgery remains controversial. This study evaluated the role of dual antiplatelet therapy using aspirin and clopidogrel (DAPT) versus antiplatelet therapy using aspirin only (ASA) on post-CABG clinical outcomes and costs. In the...